logo-loader
viewIXICO PLC

IXICO's Lammert Albers discusses expanded contract for imaging services with Vaccinex

IXICO PLC's (LON:IXI) chief business officer Lammert Albers talks Proactive's Andrew Scott through an extended contract they've secured with Vaccinex Inc (NASDAQ:VCNX).

It's to provide services on a trial of a potential treatment for Alzheimer’s disease.

The company’s digital platform and artificial intelligence (AI) software manages and helps interpret images from magnetic resonance imaging (MRI) and other scanners.

Quick facts: IXICO PLC

Price: 69 GBX

AIM:IXI
Market: AIM
Market Cap: £32.49 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

IXICO PLC 'scaling quickly' as it reports 33% growth in first half revenue

IXICO PLC's (LON:IXI) Giulio Cerroni discusses with Proactive London's Andrew Scott the brain imaging and neuroscience data specialist's first half results. For the six months ended 31 March, IXICO reported earnings of £700,000, up from £100,000 a year ago, while revenues surged 33% to...

1 week, 4 days ago

2 min read